(Q41122869)

27 September 2017

title

A prospective study of plasma 25-hydroxyvitamin D concentration and prostate cancer risk (English)

1 reference

27 September 2017

author

Jean-Claude Souberbielle

2

Jean-Claude Souberbielle

1 reference

27 September 2017

Emmanuelle Kesse-Guyot

10

Emmanuelle Kesse-Guyot

0 references

Nathalie Druesne-Pecollo

6

Nathalie Druesne-Pecollo

0 references

Angela Sutton

Angela Sutton

4

0 references

Paule Latino-Martel

Paule Latino-Martel

3

0 references

Nathalie Charnaux

Nathalie Charnaux

5

0 references

Mathilde Touvier

Mathilde Touvier

12

0 references

Khaled Ezzedine

Khaled Ezzedine

11

0 references

Pilar Galan

Pilar Galan

7

0 references

Serge Hercberg

Serge Hercberg

8

0 references

Mélanie Deschasaux

1

Mélanie Deschasaux

1 reference

27 September 2017

9

Sigrid Le Clerc

1 reference

27 September 2017

publication date

16 November 2015

1 reference

British Journal of Nutrition

27 September 2017

published in

1 reference

27 September 2017

volume

115

1 reference

27 September 2017

issue

2

1 reference

27 September 2017

page(s)

305-314

1 reference

Serum 25-hydroxyvitamin D, parathyroid hormone, and bone mineral density in men: the Rancho Bernardo study

27 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS0007114515004353

Prediagnostic circulating parathyroid hormone concentration and colorectal cancer in the European Prospective Investigation into Cancer and Nutrition cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114515004353

Vitamin D, PTH, and calcium and the risk of prostate cancer: a prospective nested case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114515004353

Variability and reproducibility of circulating vitamin D in a nationwide U.S. population

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114515004353

Dynamics of parathyroid hormone secretion in health and secondary hyperparathyroidism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114515004353

Serum 25-hydroxy vitamin D and prostate cancer risk in a large nested case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114515004353

1Alpha,25-dihydroxyvitamin D3 reduces c-Myc expression, inhibiting proliferation and causing G1 accumulation in C4-2 prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114515004353

A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114515004353

Dietary vitamin D₃ and 1,25-dihydroxyvitamin D₃ (calcitriol) exhibit equivalent anticancer activity in mouse xenograft models of breast and prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114515004353

The role of vitamin D in reducing cancer risk and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114515004353

Vitamin D, season, and risk of prostate cancer: a nested case-control study within Norwegian health studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114515004353

Plasma vitamin D and prostate cancer risk: results from the Selenium and Vitamin E Cancer Prevention Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114515004353

Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: A longitudinal, nested case‐control study in the Nordic countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114515004353

Positive association between circulating 25-hydroxyvitamin D levels and prostate cancer risk: new findings from an updated meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114515004353

Overproduction of an amino-terminal form of PTH distinct from human PTH(1-84) in a case of severe primary hyperparathyroidism: influence of medical treatment and surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114515004353

Interpretation of plasma PTH concentrations according to 25OHD status, gender, age, weight status, and calcium intake: importance of the reference values

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114515004353

Determinants of vitamin D status in Caucasian adults: influence of sun exposure, dietary intake, sociodemographic, lifestyle, anthropometric, and genetic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114515004353

A primary prevention trial using nutritional doses of antioxidant vitamins and minerals in cardiovascular diseases and cancers in a general population: the SU.VI.MAX study--design, methods, and participant characteristics. SUpplementation en VItamin

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114515004353

Vitamin D pathway gene variants and prostate cancer prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114515004353

Determinants of serum calcium in men and women. The Tromsø Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114515004353

Common genetic variation of the calcium-sensing receptor and lethal prostate cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114515004353

Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114515004353

Genetic variation in the vitamin d pathway in relation to risk of prostate cancer--results from the breast and prostate cancer cohort consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114515004353

Insulin-like growth factor-I concentration and risk of prostate cancer: results from the European Prospective Investigation into Cancer and Nutrition

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114515004353

Associations of vitamin D pathway genes with circulating 25-hydroxyvitamin-D, 1,25-dihydroxyvitamin-D, and prostate cancer: a nested case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114515004353

Lack of association between vitamin D receptor gene FokI and BsmI polymorphisms and prostate cancer risk: an updated meta-analysis involving 21,756 subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114515004353

Systematic review and meta-analysis on vitamin D receptor polymorphisms and cancer risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114515004353

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114515004353

Prospective Population-Based Study of the Association between Serum 25-Hydroxyvitamin-D Levels and the Incidence of Specific Types of Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114515004353

Adjustment for total energy intake in epidemiologic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114515004353

7 January 2021

Parathyroid hormone may be a cancer promoter - an explanation for the decrease in cancer risk associated with ultraviolet light, calcium, and vitamin D

1 reference

https://api.crossref.org/works/10.1017%2FS0007114515004353

7 January 2021

From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health

1 reference

https://api.crossref.org/works/10.1017%2FS0007114515004353

7 January 2021

Overview of general physiologic features and functions of vitamin D.

1 reference

https://api.crossref.org/works/10.1017%2FS0007114515004353

7 January 2021

Analytical validation of the Roche 25-OH Vitamin D Total assay

1 reference

https://api.crossref.org/works/10.1017%2FS0007114515004353

7 January 2021

Calcium, vitamin D, and dairy product intake and prostate cancer risk: the Multiethnic Cohort Study

1 reference

https://api.crossref.org/works/10.1017%2FS0007114515004353

7 January 2021

Effects of the calciotrophic peptides calcitonin and parathyroid hormone on prostate cancer growth and chemotaxis

1 reference

https://api.crossref.org/works/10.1017%2FS0007114515004353

7 January 2021

Growth hormone/insulin-like growth factor-1/PTH axis in bone

1 reference

https://api.crossref.org/works/10.1017%2FS0007114515004353

7 January 2021

10.1017/S0007114515004353

Identifiers

DOI

1 reference

27 September 2017

1 reference